ACSL4 Modulates Ferroptosis-Associated Injury and Mitochondrial Dysfunction in MC3T3-E1 Cells
Abstract
: Objective: Iron overload may impair bone-forming cells partly through ferroptosis-associated lipid peroxidation. This study examined the role of acyl-CoA synthetase long-chain family member 4 (ACSL4) in ferroptosis-associated injury and mitochondrial dysfunction in ferric ammonium citrate (FAC)-treated MC3T3-E1 osteoblast-like cells. It assessed the functional involvement of estrogen-related receptor alpha (ERR α ) and SRY-box transcription factor 9 (SOX9). Methods: We established an in vitro iron-overload model by exposing MC3T3-E1 osteoblast-like cells to ferric ammonium citrate (FAC). Cell viability, malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), intracellular Fe 2+ , mitochondrial membrane potential, mitochondrial reactive oxygen species (mtROS), and ATP content were assessed. ACSL4 was knocked down or overexpressed, and ERR α or SOX9 was knocked down in the ACSL4-silenced background. Results: Relative to control, FAC reduced cell viability by approximately 54%, increased MDA and 4-HNE by about 3.0-fold and intracellular Fe 2+ by about 2.1-fold, increased mtROS by about 6.2-fold, and reduced mitochondrial membrane potential and ATP content by approximately 58% and 50%, respectively (all p < 0.05). Ferrostatin-1 attenuated these changes, whereas erastin exacerbated them. ACSL4 knockdown mitigated, and ACSL4 overexpression aggravated, the FAC-associated changes. Both ERR α and SOX9 mRNA and protein abundance changed inversely with ACSL4 expression; knockdown of either factor attenuated the protective phenotype associated with ACSL4 silencing. Conclusion: In FAC-treated MC3T3-E1 cells, ACSL4 contributes to a ferroptosis-associated injury phenotype and mitochondrial dysfunction, with functional involvement of ERR α and SOX9. The direct molecular relationships and relevance to osteoporosis in vivo remain to be established.